Basiliximab |
Simulect |
Basiliximab (Simulect) is a chimeric mouse-human monoclonal antibody to the IL-2Rα receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants. It is a Novartis Pharmaceuticals product and was approved by the FDA in 1998.
GoldBamboo
Image:Basiliximab.png Basiliximab Systematic (IUPAC) name Chimeric ...
Wikipedia - [full article]

Not Signed In -


